Kent Kanao

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

International cancer conference journal

BJUI compass

The Prostate

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report. International cancer conference journal 13 (3) (2024)
Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report. International cancer conference journal 13 (3) (2024)
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, Keishiro Fukumoto, Daisuke Igarashi, Takayuki Takahashi, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Ryuichi Mizuno, Masaru Ishida, Satoshi Hara, Mototsugu Oya, Masafumi Oyama
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma. BJUI compass 5 (2) (2023)
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, Keishiro Fukumoto, Daisuke Igarashi, Takayuki Takahashi, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Ryuichi Mizuno, Masaru Ishida, Satoshi Hara, Mototsugu Oya, Masafumi Oyama
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma. BJUI compass 5 (2) (2023)
Kent Kanao, Takayuki Takahashi, Yuta Umezawa, Takashi Okabe, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Masafumi Oyama
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone. PloS one 17 (10) (2022)
Masahito Watanabe, Kent Kanao, Susumu Suzuki, Hiroyuki Muramatsu, Singo Morinaga, Keishi Kajikawa, Ikuo Kobayashi, Genya Nishikawa, Yoshiharu Kato, Kenji Zennami, Kogenta Nakamura, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Ryuzo Ueda, Makoto Sumitomo
Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis. The Prostate 79 (14) (2019)

Kent Kanao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kent Kanao